Preston Klassen Regulus Therapeutics Inc. (RGLS) insider trading activity

RGLS Quotes by TradingView

Preston Klassen is President & Head of R & D of Regulus Therapeutics Inc.. Currently has a direct ownership of 36,055 shares of RGLS, which is worth approximately $42,184. The most recent transaction as insider was on Jan 13, 2025, when has been sold 31,445 shares (Common Stock) at a price of $1.26 per share, resulting in proceeds of $39,620. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.1K
n/a 3M change
n/a 12M change
Total Value Held $42,184

Preston Klassen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 13 2025
SELL
Open market or private sale
$39,620 $1.26 p/Share
31,445 Reduced 46.59%
36,055 Common Stock
Jan 09 2025
BUY
Grant, award, or other acquisition
$89,775 $1.33 p/Share
67,500 Added 50.0%
67,500 Common Stock

Also insider at

MTCR
Metacrine, Inc. Healthcare
Director
PK

Preston Klassen

President & Head of R & D
San Diego, CA

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGLS